+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Pain"

From
Cancer Pain Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cancer Pain Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Cancer Supportive Care Market 2024-2028 - Product Thumbnail Image

Cancer Supportive Care Market 2024-2028

  • Report
  • October 2024
  • 188 Pages
  • Global
From
From
Advanced Cancer Pain Management - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2024

  • Drug Pipelines
  • June 2024
  • 60 Pages
  • Global
From
From
From
From
Cancer Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cancer Pain - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator

Cancer pain is a common symptom of cancer and its treatments. It is caused by the tumor pressing on nerves, bones, or organs, or by the side effects of chemotherapy, radiation, or surgery. It can range from mild to severe and can be managed with medications, physical therapy, and other treatments. Oncology drugs are used to treat cancer and its symptoms, including cancer pain. These drugs can be divided into two categories: analgesics, which are used to reduce pain, and adjuvant drugs, which are used to reduce the side effects of cancer treatments. Analgesics include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. Adjuvant drugs include corticosteroids, antidepressants, and antispasmodics. The cancer pain market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of cancer, the development of new drugs, and the increasing demand for pain relief. Some companies in the cancer pain market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more